Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe R Anderson

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cardiology in Review|February 18, 2016
PCSK9 Inhibitors: An Innovative Approach to Treating HyperlipidemiaAlexandra M Sible, James J Nawarskas, Joe R Anderson
Heart Disease (Hagerstown, Md.)|September 25, 2003
Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failureTera D Moore, James J Nawarskas, Joe R Anderson
Cardiology in Review|July 29, 2016
Treating Diuretic Resistance: An OverviewBrandi N Bowman, James J Nawarskas, Joe R Anderson
Core Evidence|November 21, 2015
Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based reviewAdam M Henrie, James J Nawarskas, Joe R Anderson
Cardiology in Review|August 18, 2005
Glucose-insulin-potassium therapy in the era of coronary revascularizationCara L Leos, Jennifer E Griego, Joe R Anderson
Psychological Reports|October 7, 2010
Psychometric properties of the Purdue Pharmacist Directive Guidance (PPDG) Scale in a sample of diabetes patients in the Southwestern United StatesJoe R Anderson, Lisa R Marr-Lyon, Gireesh V Gupchup
Research in Social & Administrative Pharmacy : RSAP|April 2, 2011
An evaluation of the psychometric properties of the Purdue Pharmacist Directive Guidance Scale using SPSS and R software packagesLisa R Marr-Lyon, Gireesh V Gupchup, Joe R Anderson
Psychological Reports|February 18, 2011
Split-half and parallel reliabilities of the Purdue Pharmacist Directive Guidance ScaleLisa R Marr-Lyon, Joe R Anderson, Gireesh V Gupchup
Cardiology in Review|October 15, 2015
Sacubitril/Valsartan: A Novel Cardiovascular Combination AgentAlexandra M Sible, James J Nawarskas, David Alajajian, et al.
Journal of Managed Care & Specialty Pharmacy|May 27, 2014
Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New MexicoXian Shen, Amy Bachyrycz, Joe R Anderson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cardiology in Review|February 18, 2016
PCSK9 Inhibitors: An Innovative Approach to Treating HyperlipidemiaAlexandra M Sible, James J Nawarskas, Joe R Anderson
Heart Disease (Hagerstown, Md.)|September 25, 2003
Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failureTera D Moore, James J Nawarskas, Joe R Anderson
Cardiology in Review|July 29, 2016
Treating Diuretic Resistance: An OverviewBrandi N Bowman, James J Nawarskas, Joe R Anderson
Core Evidence|November 21, 2015
Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based reviewAdam M Henrie, James J Nawarskas, Joe R Anderson
Cardiology in Review|August 18, 2005
Glucose-insulin-potassium therapy in the era of coronary revascularizationCara L Leos, Jennifer E Griego, Joe R Anderson
Psychological Reports|October 7, 2010
Psychometric properties of the Purdue Pharmacist Directive Guidance (PPDG) Scale in a sample of diabetes patients in the Southwestern United StatesJoe R Anderson, Lisa R Marr-Lyon, Gireesh V Gupchup
Research in Social & Administrative Pharmacy : RSAP|April 2, 2011
An evaluation of the psychometric properties of the Purdue Pharmacist Directive Guidance Scale using SPSS and R software packagesLisa R Marr-Lyon, Gireesh V Gupchup, Joe R Anderson
Psychological Reports|February 18, 2011
Split-half and parallel reliabilities of the Purdue Pharmacist Directive Guidance ScaleLisa R Marr-Lyon, Joe R Anderson, Gireesh V Gupchup
Cardiology in Review|October 15, 2015
Sacubitril/Valsartan: A Novel Cardiovascular Combination AgentAlexandra M Sible, James J Nawarskas, David Alajajian, et al.
Journal of Managed Care & Specialty Pharmacy|May 27, 2014
Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New MexicoXian Shen, Amy Bachyrycz, Joe R Anderson, et al.
Pageof 4